Display scaffolds: protein engineering for novel therapeutics

Area of Science:

• Biochemistry
• Immunology
• Drug Discovery

Background:

• Protein scaffolds are emerging as a novel class of universal binding frameworks.
• They aim to complement existing therapeutic monoclonal antibodies in immunopharmaceutical applications.
• Advances in engineering minimal binding domains and molecular libraries are key to their development.

Purpose of the Study:

• To review recent literature on protein scaffold development.
• To highlight advances in engineering minimal immunoglobulin-based binding domains and molecular library design.
• To discuss potential therapeutic and intracellular applications and progress towards clinical trials.

Main Methods:

• Review of recent scientific literature on protein scaffold development.
• Analysis of engineering strategies for minimal immunoglobulin-based binding domains.
• Examination of molecular library design approaches.
• Assessment of modular construction principles in scaffold design.
• Evaluation of scaffold-specific features for targeting non-conventional antigens.

Main Results:

• Several diverse protein folds are under development using modular construction.
• Scaffold-specific features offer advantages for targeting non-conventional antigens.
• Designed scaffolds show progress and validation towards first-in-human trials.

Conclusions:

• Protein scaffolds represent a promising new generation of immunopharmaceuticals.
• Their modular design and versatility offer distinct advantages over traditional antibodies.
• Continued development and validation are paving the way for clinical applications.